Market Overview - US stock index futures showed mixed performance, with Dow futures up by 0.59% and S&P 500 futures up by 0.12%, while Nasdaq futures declined by 0.05% [1] - European indices had varied results, with Germany's DAX up by 0.09%, UK's FTSE 100 down by 0.11%, France's CAC40 up by 0.58%, and the Euro Stoxx 50 up by 0.27% [2][3] - WTI crude oil prices fell by 0.53% to $63.62 per barrel, while Brent crude oil prices decreased by 0.39% to $66.58 per barrel [3][4] Geopolitical Events - A significant meeting is scheduled between US President Trump and Russian President Putin in Alaska, focusing on the Russia-Ukraine conflict and peace prospects, marking their first in-person meeting in four years [5] Federal Reserve Insights - Federal Reserve Chairman Powell is set to speak at the Jackson Hole conference on August 22, with market expectations leaning towards a potential 25 basis point rate cut due to inflation and a slowing job market [6] - Bank of America warns that if the Fed signals a dovish stance at Jackson Hole, US stocks may face a "buy the rumor, sell the news" scenario, indicating potential market corrections [7] Hedge Fund Activity - Hedge funds have significantly increased their holdings in technology stocks during Q2, with notable purchases in Microsoft and Netflix, amidst a backdrop of market volatility due to trade policies [8] Economic Concerns - Bank of America raised concerns about the potential for the dollar to face challenges if the Fed lowers rates while inflation is rising, a scenario not seen in nearly 20 years [9] Company Performance - Tuniu (TOUR.US) reported a 15.3% year-over-year increase in Q2 revenue, with a new $10 million stock buyback plan announced [10] - New Oxygen (SY.US) experienced a 7.0% decline in Q2 revenue, attributed to a decrease in the number of medical service providers subscribing to its platform [11] - Applied Materials (AMAT.US) provided disappointing Q4 guidance, raising concerns about demand suppression due to US-China trade tensions [11] - Cloud Mi Technology (VIOT.US) expects over 1.4 billion RMB in revenue for the first half of 2025, a growth of over 70% year-over-year, driven by increased sales of home water purification devices [12]

Financial Performance - New Oxygen (SY.US) reported Q2 revenue of 378.7 million RMB, a year-on-year decrease of 7.0%, exceeding market expectations [1] - The company posted a net loss of 36 million RMB, compared to a net profit of 18.9 million RMB in the same period last year [1] - The loss per ADS was 0.35 RMB, down from a profit of 0.18 RMB per ADS in the previous year [1] Revenue Breakdown - Revenue from beauty treatment services was 144.4 million RMB, a significant year-on-year increase of 426.1% [1] - Revenue from information and booking services was 135.2 million RMB, a year-on-year decrease of 35.6% [1] - Sales from medical products and maintenance services were 76 million RMB, down 28.1% year-on-year [1] - Other service income decreased by 64.0% to 23.2 million RMB [1] User Engagement - The total transaction volume facilitated by New Oxygen's platform for medical beauty was 303.9 million RMB, compared to 427.8 million RMB in the same period of 2024 [1] - The number of active users exceeded 100,400, a significant increase from approximately 16,000 in the previous year [2] - The company operates 29 fully operational brand aesthetic centers across nine major cities, with 25 centers achieving positive monthly operating cash flow [2] Future Guidance - For Q3 2025, New Oxygen expects revenue from beauty treatment services to be between 150 million and 170 million RMB, representing a year-on-year growth of 230.5% to 274.6% [3]

1 Phase (The length of time since establishment) Number of Centers Revenue (RMB) Average Revenue per Center (RMB) Ramp-up (0-3 months) 9 23,554,000 2,617,000 Growth (4-12 months) 14 89,644,000 6,403,000 Maturity (over 12 months) 6 31,192,000 5,199,000 This press release contains translations of certain Renminbi (RMB) amounts into U.S. dollars (US$) solely for the convenience of the reader. Unless otherwise specified, all translations of Renminbi amounts into U.S. dollar amounts in this press release are mad ...

Core Viewpoint - So-Young International Inc. reported its second quarter financial results for 2025, highlighting a significant transformation in its revenue structure, with aesthetic treatment services becoming the largest revenue contributor for the first time, despite an overall revenue decline compared to the previous year [1][5][6]. Financial Highlights - Total revenues for Q2 2025 were RMB 378.7 million (US$ 52.9 million), a decrease of 7.0% from RMB 407.4 million in Q2 2024 [6][7]. - Aesthetic treatment services revenues increased to RMB 144.4 million (US$ 20.2 million), up 426.1% from RMB 27.4 million in the same period of 2024 [7][8]. - Net loss attributable to So-Young was RMB 36.0 million (US$ 5.0 million), compared to a net income of RMB 18.9 million in Q2 2024 [15][16]. - Non-GAAP net loss was RMB 30.5 million (US$ 4.3 million), contrasting with a non-GAAP net income of RMB 22.2 million in the same period of 2024 [16][22]. Operational Highlights - The number of verified treatment visits to branded aesthetic centers exceeded 67,400, compared to approximately 14,000 in Q2 2024 [7]. - The number of active users visiting branded aesthetic centers in the last 12 months surpassed 100,400, compared to around 16,000 in the same period of 2024 [7]. - As of June 30, 2025, So-Young operated 29 branded aesthetic centers across nine major cities in China, with 25 centers achieving positive monthly operating cash flow [7][8]. Cost and Expenses - Cost of revenues was RMB 184.6 million (US$ 25.8 million), an increase of 19.0% from RMB 155.1 million in Q2 2024, primarily due to the expansion of branded aesthetic centers [11]. - Total operating expenses were RMB 241.3 million (US$ 33.7 million), a slight decrease of 1.8% from RMB 245.6 million in Q2 2024 [12]. Business Outlook - For Q3 2025, So-Young expects aesthetic treatment services revenues to be between RMB 150.0 million (US$ 20.9 million) and RMB 170.0 million (US$ 23.7 million), representing a projected increase of 230.5% to 274.6% from the same period in 2024 [21].

本文源自：智通财经网 智通财经获悉，周三，新氧(SY.US)股价走高，截至发稿，该股涨超7.7%，报5.181美元。该公司将于08 月15日盘前发布最新财报。 ...

周三，新氧(SY.US)股价走高，截至发稿，该股涨超7.7%，报5.181美元。该公司将于08月15日盘前发布 最新财报。 ...

智通财经APP获悉，周三，新氧(SY.US)股价走高，截至发稿，该股涨超7.7%，报5.181美元。该公司将 于08月15日盘前发布最新财报。 ...

Group 1 - The core viewpoint of the news is that Xinyang (SY) experienced a stock price increase of 6.03%, reaching $5.1 per share, with a total market capitalization of $511 million as of August 13 [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue was 297 million RMB, representing a year-on-year decrease of 6.6%, while the net profit attributable to shareholders was -33.138 million RMB, a decline of 56.02% year-on-year [1] Group 2 - A significant event reminder states that Xinyang is scheduled to disclose its fiscal year 2025 mid-term report on August 15, before the market opens in the Eastern Time Zone [2] - Xinyang International Company focuses on leveraging technology to assist women in enhancing their beauty and health, aiming to transform the opaque medical aesthetics market in China into a transparent one [2]

Group 1 - The core viewpoint of the article highlights that Xinyang (SY) experienced a stock price increase of 2.08% on August 13, closing at $4.91 per share, with a total market capitalization of $492 million [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue amounted to 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to shareholders was -33.138 million RMB, a decline of 56.02% year-on-year [1] - Xinyang is set to disclose its fiscal year 2025 mid-term report on August 15, prior to the market opening in the Eastern Time Zone [2] Group 2 - Xinyang International Company focuses on leveraging technology to assist women in enhancing their health and beauty [2] - The founder established Xinyang to provide transparent information, aiming to transform the rapidly growing yet opaque medical aesthetics market in China [2] - The ultimate goal is to create a one-stop platform where users can conveniently find high-quality services [2]

Group 1 - The core viewpoint of the article highlights that Xinyang (SY) experienced a stock price increase of 5.54% on August 12, reaching $4.855 per share, with a total market capitalization of $487 million [1] - Financial data indicates that as of March 31, 2025, Xinyang's total revenue was 297 million RMB, reflecting a year-on-year decrease of 6.6%, while the net profit attributable to the parent company was -33.138 million RMB, a decline of 56.02% year-on-year [1] Group 2 - A significant event reminder states that Xinyang is scheduled to disclose its fiscal year 2025 mid-term report on August 15, before the market opens in the Eastern Time zone [2] - Xinyang International Company is dedicated to leveraging technology to assist women in enhancing their health and beauty, aiming to transform the opaque medical aesthetics market in China into a transparent one, ultimately establishing a one-stop platform for users to easily find quality services [2]